首页> 美国卫生研究院文献>other >Peroxynitrite and Protein Nitration in the Pathogenesis of Diabetic Peripheral Neuropathy
【2h】

Peroxynitrite and Protein Nitration in the Pathogenesis of Diabetic Peripheral Neuropathy

机译:糖尿病周围神经病变发病机理中的过氧化亚硝酸盐和蛋白质硝化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Peroxynitrite, a product of the reaction of superoxide with nitric oxide, causes oxidative stress with concomitant inactivation of enzymes, poly(ADP-ribosylation), mitochondrial dysfunction, impaired stress signaling, as well as protein nitration. In this study we sought to determine the effect of preventing protein nitration or increasing peroxynitrite decomposition on diabetic neuropathy in mice after an extended period of untreated diabetes. C57Bl6/J male control and diabetic mice were treated with the peroxynitrite decomposition catalyst Fe(III) tetramesitylporphyrin octasulfonate (FeTMPS, 10 mg/kg/d) or protein nitration inhibitor (−)-epicatechin gallate (20 mg/kg/d) for 4 weeks, after an initial 28 weeks of hyperglycemia. Untreated diabetic mice developed motor and sensory nerve conduction velocity deficits, thermal and mechanical hypoalgesia, tactile allodynia, and loss of intraepidermal nerve fibers. Both FeTMPS and epicatechin gallate partially corrected sensory nerve conduction slowing and small sensory nerve fiber dysfunction without alleviation of hyperglycemia. Correction of motor nerve conduction deficit and increase in intraepidermal nerve fiber density were found with FeTMPS treatment only. In conclusion, peroxynitrite injury and its component, protein nitration, are implicated in the development of diabetic peripheral neuropathy. The findings indicate that both structural and functional changes of chronic diabetic peripheral neuropathy can be reversed, and provide rationale for the development of a new generation of antioxidants and peroxynitrite decomposition catalysts, for treatment of diabetic peripheral neuropathy.
机译:过氧亚硝酸盐是超氧化物与一氧化氮反应的产物,会引起氧化应激,并伴随酶的失活,聚(ADP-核糖基化),线粒体功能障碍,应激信号减弱以及蛋白质硝化。在这项研究中,我们试图确定在长时间未治疗的糖尿病中,预防蛋白质硝化或增加过氧亚硝酸盐分解对小鼠糖尿病性神经病变的作用。 C57B16 / J雄性对照组和糖尿病小鼠用过亚硝酸盐分解催化剂四(三甲基)卟啉八磺酸铁(FeTMPS,10 mg / kg / d)或蛋白质硝化抑制剂(-)-表儿茶素没食子酸酯(20 mg / kg / d)处理在最初的28周高血糖症发生后的4周内。未经治疗的糖尿病小鼠出现运动和感觉神经传导速度缺陷,热和机械性痛觉过敏,触觉异常性疼痛以及表皮内神经纤维丢失。 FeTMPS和表儿茶素没食子酸酯均部分纠正了感觉神经传导减慢和小感觉神经纤维功能障碍,但并未缓解高血糖症。仅用FeTMPS治疗可纠正运动神经传导缺陷和增加表皮内神经纤维密度。总之,过氧亚硝酸盐损伤及其成分,蛋白质硝化与糖尿病周围神经病的发展有关。这些发现表明,慢性糖尿病周围神经病变的结构和功能变化均可逆转,并为开发新一代抗氧化剂和过氧亚硝酸盐分解催化剂的发展提供了理论依据,用于治疗糖尿病周围神经病变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号